Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is part of the Tomorrow's Treatments segment. BMED's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, HRTS's top sector exposures are Health Care BMED is less expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.99% for HRTS. BMED is down -5.49% year-to-date (YTD) with +$4M in YTD flows. HRTS performs better with -4.67% YTD performance, and -$713K in YTD flows. Run a side-by-side ETF comparison of BMED and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED HRTS | -6.03%-5.84% | -5.68%-4.63% | -5.49%-4.67% | +16.79%+15.66% | +27.36%n/a | -1.83%n/a |
| Flows | BMED HRTS | +$1M-$2M | +$4M+$712K | +$4M-$713K | +$7M-$17M | +$4M- | +$5M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED HRTS | +15.26%+14.54% | +17.92%+17.68% | +15.51%n/a | +17.58%n/a |
| Max drawdown | BMED HRTS | -10.40%-7.89% | -14.01%-13.50% | -19.76%n/a | -33.96%n/a |
| Max drawdown duration | BMED HRTS | 50d65d | 113d163d | 237dn/a | 1586dn/a |
BMED | HRTS | |
Last sale 3/13/2026 at 1:30 PM | $28.63 | $33.67 |
| Previous close 03/12/2026 | $28.78 | $33.85 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
BMED | HRTS | |
|---|---|---|
| Last price | $28.63 | $33.67 |
| 1D performance | -0.52% | -0.54% |
| AuM | $10.31 M | $51.53 M |
| E/R | 0.77% | 0.99% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
